Skip to content

凯睿思生命科学

US · CAI #1669 按市值排名 上市于 2025
30.56 -1.20 -3.78%
实时 - 追踪5344个代码 - 心跳于11秒前 · 2026-10-16 20:01

最新新闻

  • 公司公告
    UOB Kay Hian: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED
    SGX · 2026/9/8
  • 公司公告
    UOB Kay Hian: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED
    SGX · 2026/9/3
  • 评级变动
    I-MAB Buy Rating: Strategic Pivot to U.S. Market and Promising Pipeline
    TipRanks · 2024/2/12
  • Trump: The U.S.-Iran war has reached a critical juncture, and I am facing a major decision.
    cls.cn · 2026/9/18
  • Fed's Barr Says Resilience Of U.S. Economy Is Striking; I Don't Have Recession In My Base Case; Momentum Seems To Be Building In The Economy
    Benzinga · 2026/9/30
  • 公司公告
    UOB Kay Hian: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED
    SGX · 2026/9/14
  • 公司公告
    FLOWING CLOUD: REVISED EXPECTED TIMETABLE IN RELATION TO(I) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL;(II) PROPOSED CHANGE IN BOARD LOT SIZE;AND(III) PROPOSED RIGHTS ISSUE ON THE BASIS OFFOUR (4) RIGHTS SHARES FOR EVERY ONE (1) SHAREHELD ON THE RECORD DATE ON A NON-U
    HKEX · 2026/10/5
  • U.S. Stock Market Moves | Ferrovial rises 3.6% in pre-market trading after securing $9.2 billion public-private partnership for Tennessee I-24 Express Lanes
    Gelonghui Finance · 2026/8/20
  • U.S. Treasury Secretary Bessent: Trump and I have full confidence in Federal Reserve Chair Warsh
    Breakings · 2026/9/21
  • U.S. stocks are clearly in a state of "euphoria"! Howard Marks: This is one of the most challenging situations I have encountered in my investment career, but uncertainty about the future is not a reason to refrain from investing...
    The Intelligent Investor · 2026/9/7
  • 公司公告
    ASCLETIS-B: VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF PHASE I STUDY IN U.S.FOR ORAL AMYLIN RECEPTOR PEPTIDE AGONIST ASC36 FOR THETREATMENT OF OBESITY
    HKEX · 2026/9/8

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:01:23 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

凯睿思生命科学 讨论区 0 条评论

发表评论